Catalyst Wire Dossier Catalyst Wire Dossier

ABBV-903

· AbbVie
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABBV-903, covering 2024-09-20 to 2024-09-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Relative Bioavailability of Three Immediate-Release Tablet Formulations of ABBV-903 in Healthy Adult Volunteers [Phase 1]

See pricing